Region Asia Pacific. Ian Alexander. Executive Vice President Asia Pacific

Size: px

Start display at page:

Download "Region Asia Pacific. Ian Alexander. Executive Vice President Asia Pacific"

Pauline Morris
5 years ago
Views:

1 Region Asia Pacific Ian Alexander Executive Vice President Asia Pacific

Market area - Region Asia Pacific no machines less than 1 between 1-3 between 3-5 5 or more Source: DIRAC/IAEA Elekta serves 15 major

less than 30% of the linear accelerators (linacs) Population aged 65 and over ranges from less than 5% (Bangladesh, Indonesia) to

2,100 radiation oncology facilities across the region with almost 3,000 linacs Demand for cancer treatment remains highly diversified

2 Market area - Region Asia Pacific no machines less than 1 between 1-3 between or more Source: DIRAC/IAEA Elekta serves 15 major markets across the region Seven direct operations plus a network of distributors in other markets Almost 60% of the world population but less than 30% of the linear accelerators (linacs) Population aged 65 and over ranges from less than 5% (Bangladesh, Indonesia) to greater than 20% (Japan) Approx. 2,100 radiation oncology facilities across the region with almost 3,000 linacs Demand for cancer treatment remains highly diversified across Asian markets Shortage of trained staff remains an issue Healthcare IT and RT software business is an emerging business with quite fast adoption and growing interest High investment in new radiation therapy centers expansion through partnerships

Market dynamics Far East Market share New orders Other 10%

emerging markets Emerging markets beginning to grow.

markets Distributor business in Korea acquired Aug 1,

Malaysia Opportunity to drive software in many markets

3 Market dynamics Far East Market share New orders Other 10% Far East Markets Combination of sophisticated markets and emerging markets Emerging markets beginning to grow. Availability of skilled staff a limiting factor in many markets Distributor business in Korea acquired Aug 1, 2010; Direct Service organization from April 1, 2011 in Malaysia Opportunity to drive software in many markets Achieved 29% growth in order volume in 10/11 Siemens 4% Varian 45% 41% Elekta

Market dynamics - Japan Second largest device market globally with highly complex regulatory environment High installed base drives large replacement market,

Siemens 7% Varian 51% 28% Elekta Distribution agreement signed with Toshiba Medical.

4 Market dynamics - Japan Second largest device market globally with highly complex regulatory environment High installed base drives large replacement market, in all business areas Elekta dominates in neuroscience and treatment planning, less than 10% overall market share in oncology Market share New orders Other 14% Siemens 7% Varian 51% 28% Elekta Distribution agreement signed with Toshiba Medical. Significant future impact for oncology business Impact of March 11 earthquake, tsunami and nuclear situation still unknown; we anticipate some degree of slowdown in market in next FY Elekta achieved 6% growth in order volume in 2010/11

5 Market dynamics - China Third largest medical device market in the world - domestic manufacturers in low technology sector Continued strong growth (15-20% annually) as country strives to deliver improved healthcare Availability of skilled staff and cancer center licensing remains a limiting factor. In 2010/11 Elekta delivered >2,400 customer training days and this will increase in 2011/12 Market share New orders Other 2% Domestic 18% Siemens Varian 15% 25% 40% Elekta *incl. BMEI Elekta China now in number 1 position in oncology and well positioned to maintain market leadership Increasing demand for software to improve workflow and balance the high volume of patient treatments Achieved 17% growth in order volume in 2010/11

Elekta Elekta has a very strong software business across the market; OIS and TPS in demand due to workflow benefits Partnership

6 Market dynamics - Australia / New Zealand Market share New orders Expansive geography with low population, established market demanding high treatment capabilities Other 10% Siemens 6% Breakthrough Gamma Knife sites will drive SRS business Varian 32% 52% Elekta Elekta has a very strong software business across the market; OIS and TPS in demand due to workflow benefits Partnership agreement signed in 2010 with Genesis Care, which we expect will drive opportunities in coming years Achieved 74% growth in order volume in 2010/11.

7 Market dynamics - India Market share New orders Standard of treatment continues to improve across region but still restrained by lack of skilled staff and finance Other 6% Siemens 6% Elekta will address customer training and finance needs in FY 2011/12 Highly competitive market where demand for latest technology is acute Varian 44% 44% Elekta Estimate growth in Indian market could be as much as 35-40% annually (public and private sectors) over the next 5 years Elekta achieved 79% growth in order volume in 2010/11

8 Key highlights - China and India China India Cancer incidence/year 2.6 million 1 million, 34% rise in next 5 years Average size of treatment center: 1.13 linac/center 1.95 unit/center Installed base, all suppliers 1,278 linacs (inc 400 domestic) 270 linacs (+250 Cobalt) Market facts Annual linac units sold OIS penetration IMRT/IGRT penetration Elekta s position Market share linacs Market share - new sales linac LGK installed, of which Perfexion 160/year 50% w/ basic R&V <20% advanced 40% estimated 35% 40% 17 w / 2 Perfexion 55/year 80% w/ basic R&V <2% advanced 20% estimated 26% 44% 7 w / 3 Perfexion Market outlook Orders and sales 15-20% growth expected in 2011/ % growth expected in 2011/12

9 Cancer incidence - Treatment in India Approximately 960,000 new cases identified annually Receive radiation therapy 70% 3 70% No treatment 30% Treated Approx. 3 million cases at any time. Of the 30% who receive treatment a high percentage receive RT because patients often present in late stages

10 Competitive situation

Elekta s market position Oncology Delivery systems Units installed total 3,000 Units sold annually 300 Market share 10/11 Market share (Total Installed Base) CyberKnife 1% Tomo 2%

11 Elekta s market position Oncology Delivery systems Units installed total 3,000 Units sold annually 300 Market share 10/11 Market share (Total Installed Base) CyberKnife 1% Tomo 2% Siemens 15% Varian 36% BrainLab 2% Other 3% 41% Elekta Other 19% (Cobalt + older units) CyberKnife 1% BrainLab 1% 23% Tomo 1% Siemens 20% 35% Elekta Varian Growth of 23% in Elekta installed base

Elekta s market position Leksell Gamma Knife Asia Pacific installed base 109

BrainLab 20% Accuray 19% 61% Elekta Leksell Gamma Knife High installed base,

Developing fast growing market, i.e. China, India RO Far East 6% Australia 1%

12 Elekta s market position Leksell Gamma Knife Asia Pacific installed base 109 units 21 LGK Perfexion units 17 LGK Perfexion in backlog SRS/SRT Market share BrainLab 20% Accuray 19% 61% Elekta Leksell Gamma Knife High installed base, especially in Japan. High installed base with old systems i.e. LGKB/C/4C Great opportunity for upgrade to Perfexion. Developing fast growing market, i.e. China, India RO Far East 6% Australia 1% India 6% Taiwan 6% Korea 15% 51% Japan China 15%

13 Elekta performance

Sales development Region Asia Pacific USD M 325 300 275 250 CAGR = 25.

14 Sales development Region Asia Pacific USD M CAGR = 25.8% +40% % +23% 05/06 06/07 07/08 08/09 09/10 10/11-4.6% +36.9% +40.1% +28.4% +30.4% Neuro Software Oncology

15 Order and Revenue development Region Asia Pacific Order development Revenue development USD M USD M CAGR % 350 CAGR 286 Japan India FE China % Japan India FE China 50 ANZ 50 ANZ 0 FY 08/09 FY 09/10 FY 10/11 0 FY 08/09 FY 09/10 FY 10/11

16 Elekta strategy

17 Elekta strategy for Region Asia Pacific Continue to develop the organization; fuel the growth while delivering improving margins Customer needs; Meet the demand for products & services required in Asia: Asia disease solutions; Finance, upgrade path #1 Improved workflow; Software will continue to play an increasing role in delivering improvements at all levels Unmet demand; Centers of Training Excellence will become a feature for the region

Age of installed base report Q3 2010/11 Over 8 years old Up to 3 years old 39% 20% 41% Potential upgrade targets 80 70 60 Number of linacs 50 Potential upgrade path: Hardware upgrades

18 Age of installed base report Q3 2010/11 Over 8 years old Up to 3 years old 39% 20% 41% Potential upgrade targets Number of linacs 50 Potential upgrade path: Hardware upgrades Software upgrades Upgrade to IGRT Upgrade to VMAT / 94 94/ 95 95/ 96 96/ 97 97/ 98 98/ 99 99/ 00 00/ 01 01/ 02 02/ 03 03/ 04 04/ 05 05/ 06 06/ 07 07/ 08 08/ 09 09/ 10 10/ 11

19 Market outlook Opportunities Strong underlying market demand Aging population Cancer incidence Improving diagnostics Low installed base in emerging markets Developing organization Increasing use of talent across region Increasing investment in capabilities E&T, finance, installed base management Opportunities for expansion Some concerns Impact of Japan earthquake and tsunami Specific Asian customer needs

Summary Market will continue to develop rapidly as GDP levels increase and healthcare remains a priority Investment in further sales and support

20 Summary Market will continue to develop rapidly as GDP levels increase and healthcare remains a priority Investment in further sales and support resources to ensure that new customers can be gained and retained Elekta is well positioned to capture and maintain the number 1 position in all markets

Philips Medical Systems in Asia PMS Analyst Day, 9 June 2004

Philips Medical Systems in Asia PMS Analyst Day, 9 June 2004 Philips in Asia PMS Analyst Day, 9 June 2004 Michiel Manuel Senior Vice President CEO Sales & Service Region APAC CEO Philips China Agenda APAC Region overview Regional characteristics Business overview